Martingale Asset Management’s Viemed Healthcare VMD Stock Holding History

Martingale Asset Management’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$484K	Buy	42,421 +6	+0%	+$59	0.01%	669
2026 Q1	$391K	Sell	42,415 -68	-0.2%	-$566	0.01%	693
2025 Q4	$316K	Buy	42,483 +2,399	+6%	+$16.4K	0.01%	685
2025 Q3	$272K	Buy	40,084 +689	+2%	+$4.66K	0.01%	708
2025 Q2	$272K	Buy	39,395 +2,810	+8%	+$19.1K	0.01%	717
2025 Q1	$266K	Buy	36,585 +1,749	+5%	+$13.7K	0.01%	698
2024 Q4	$279K	Buy	34,836 +3,451	+11%	+$29.9K	0.01%	700
2024 Q3	$230K	Buy	31,385 +6,965	+29%	+$49.8K	0.01%	749
2024 Q2	$160K	Buy	24,420 +140	+0.6%	+$1.05K	﹤0.01%	770
2024 Q1	$229K	Hold	24,280	–	–	﹤0.01%	752
2023 Q4	$191K	Hold	24,280	–	–	﹤0.01%	767
2023 Q3	$163K	Buy	+24,280	New	+$199K	﹤0.01%	760

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Martingale Asset Management's VMD Position: Q2 2026 in Review

Martingale Asset Management increased its Viemed Healthcare (VMD) stake by 0.01% in Q2 2026, buying an estimated $59 and bringing the position to 42,421 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #669.

Martingale Asset Management first reported a position in VMD in Q3 2023 and has held it in 12 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Martingale Asset Management held 42,421 shares of Viemed Healthcare worth $484K as of Q2 2026.
Martingale Asset Management bought 6 Viemed Healthcare shares in Q2 2026, an estimated $59.
Viemed Healthcare made up 0.01% of Martingale Asset Management's portfolio in Q2 2026, its #669 holding.
Martingale Asset Management first reported a position in Viemed Healthcare in Q3 2023 and has held it in 12 quarters since.
166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.